Timothy F. Stanton

Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer

Matt I. Gross, Susan D. Demo, Jennifer B. Dennison et al. · Molecular Cancer Therapeutics · 2014 · 1.1K citations

Medicine, Oncology, Pharmacology +16

Design and Synthesis of an Orally Bioavailable and Selective Peptide Epoxyketone Proteasome Inhibitor (PR-047)

Han-Jie Zhou, Monette Aujay, Mark K. Bennett et al. · Journal of Medicinal Chemistry · 2009 · 272 citations · Full text

Medicine, Oncology, Pharmacology +12

Potent and Highly Selective Hypoxia-Activated Achiral Phosphoramidate Mustards as Anticancer Drugs

Hailong Jiao, Jacob A. Kaizerman, Timothy F. Stanton et al. · Journal of Medicinal Chemistry · 2008 · 239 citations

Medicine, Medicinal Chemistry, Pharmacology +17

DNA binding ligands with in vivo efficacy in murine models of bacterial infection: optimization of internal aromatic amino acids

Roland W. Bürli, Jacob A. Kaizerman, Peter Jones et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 17 citations

Life Sciences, Medicinal Chemistry, Molecular Biology +13

Discovery of a Series of Potent, Selective, and Orally Bioavailable Nucleoside Inhibitors of CD73 That Demonstrates <i>In Vivo</i> Antitumor Activity

Jim Li, Lijing Chen, Roland Billedeau et al. · Journal of Medicinal Chemistry · 2022 · 12 citations · Full text

Medicine, Oncology, Pharmacology +17